stockrowIceCure Medical Ltd.
ICCMIceCure Medical Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $3.4 million, up 2.67% from fiscal 2024.
- Revenue
- −0.69%
- EPS
- −2,068.2%
- Free cash flow
- +3.88%
- Total debt
- −64.4%
Quarter to June 2026, against a year earlier
Follow ICCM
Alert me
IceCure Medical Ltd. (ICCM) Return on invested capital
IceCure Medical Ltd.'s return on invested capital over the twelve months to 30 June 2026 was 0.00%, up 5649.0 percentage points from fiscal 2025 (−5,649.0%). Over the past ten years it has ranged from −5,649.0% (fiscal 2025) to 0.00% (fiscal 2024) — the current reading is the lowest in ten years. That is above the Medical Devices industry median of −5.22% and in line with the Healthcare sector median of 0.00%.
Return on invested capital, annual
Embed this chart
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2025 | −5,649.0% | (5,648.95) |
| FY2024 | 0.00% | 659.11 |
| FY2023 | −659.1% | (107.61) |
| FY2022 | −551.5% | (250.93) |
| FY2021 | −300.6% | (186.23) |
| FY2020 | −114.3% | (114.34) |
| FY2019 | 0.00% | 0.00 |
| FY2018 | 0.00% | 0.00 |
| FY2017 | 0.00% | 0.00 |
| FY2016 | 0.00% | — |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| NUWE Nuwellis, Inc. compare | 0.00% |
| AIDX 20/20 Biolabs Inc. compare | 0.00% |
| AMIX Autonomix Medical, Inc. compare | 0.00% |
| BJDX Bluejay Diagnostics, Inc. compare | 0.00% |
| ICCM IceCure Medical Ltd. | 0.00% |
| NUVOQ Holdco Nuvo Group D.G Ltd. compare | 0.00% |
| IVF INVO Fertility, Inc compare | −27.9% |
| ADGM Adagio Medical Holdings, Inc. compare | −74.6% |
| CODX Co-Diagnostics, Inc. compare | −337.7% |
| Medical Devices industry median | −5.22% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)